Mitchell Freidberg

Mitchell Freidberg has extensive experience in various roles within the biopharmaceutical industry. Mitchell is currently serving as the Head of Strategic Insights & Commercial Operations at Iveric Bio since July 2022. Prior to this, they worked at Applied Therapeutics, Inc. as the Vice President Of Commercial Operations from August 2020 to August 2022. Before that, Mitchell held multiple positions at SUN PHARMA, including Associate Vice President, Head of Commercial Operations from April 2018 to July 2020, and Head Of Commercial Operations from July 2016 to March 2018.

Before joining SUN PHARMA, Mitchell served as the President of JMK Healthcare Consulting LLC from May 2008 to July 2016. Mitchell has also gained experience at Heron Therapeutics, Inc. as the Senior Director, Sales Operations & Training from July 2015 to January 2016, and at Sandoz as the Director Sales Operations from October 2014 to July 2015.

Furthermore, Mitchell has held positions at Mylan Specialty L.P. as the Director, Sales Operations from July 2011 to March 2014, at Allos Therapeutics, inc. as the Sr. Director, Corporate Operations from October 2008 to January 2011, at PDI, Inc. as the Vice President, Sales Operations & Informatics from March 2007 to May 2008, and at Genta Incorporated as the Director, Oncology Operations from March 2006 to December 2006.

Mitchell Freidberg has attended the University of Delaware, but there is no information available regarding the degree, field of study, start year, or end year.